X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3221) 3221
Book Review (435) 435
Newsletter (108) 108
Publication (95) 95
Newspaper Article (46) 46
Book / eBook (40) 40
Magazine Article (4) 4
Conference Proceeding (3) 3
Book Chapter (2) 2
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3063) 3063
index medicus (2966) 2966
male (1765) 1765
female (1473) 1473
middle aged (1359) 1359
laryngeal neoplasms - drug therapy (1281) 1281
aged (1121) 1121
adult (962) 962
laryngeal neoplasms - pathology (847) 847
cancer (833) 833
otorhinolaryngology (787) 787
oncology (772) 772
laryngeal neoplasms - surgery (627) 627
laryngeal neoplasms - radiotherapy (622) 622
carcinoma, squamous cell - drug therapy (579) 579
laryngeal cancer (537) 537
radiotherapy (521) 521
combined modality therapy (511) 511
surgery (503) 503
treatment outcome (497) 497
chemotherapy (492) 492
carcinoma, squamous cell - pathology (487) 487
squamous-cell carcinoma (448) 448
head (447) 447
neoplasm staging (394) 394
laryngeal neoplasms - therapy (393) 393
care and treatment (384) 384
abridged index medicus (378) 378
retrospective studies (376) 376
carcinoma, squamous cell - radiotherapy (371) 371
larynx (360) 360
prognosis (344) 344
aged, 80 and over (328) 328
squamous cell carcinoma (325) 325
neck-cancer (316) 316
antineoplastic combined chemotherapy protocols - therapeutic use (311) 311
head and neck neoplasms - drug therapy (307) 307
research (299) 299
follow-up studies (297) 297
antineoplastic agents - therapeutic use (284) 284
cell line, tumor (282) 282
carcinoma (272) 272
head and neck cancer (270) 270
neck (254) 254
radiation-therapy (240) 240
laryngeal neoplasms - mortality (238) 238
animals (237) 237
laryngeal neoplasms - diagnosis (232) 232
analysis (227) 227
laryngectomy (226) 226
laryngeal neoplasms - metabolism (225) 225
apoptosis (219) 219
carcinoma, squamous cell - surgery (213) 213
child (213) 213
cisplatin - administration & dosage (213) 213
otolaryngology (213) 213
head and neck neoplasms - radiotherapy (209) 209
head and neck neoplasms - pathology (204) 204
carcinoma, squamous cell - therapy (202) 202
adolescent (198) 198
carcinoma, squamous cell - mortality (192) 192
survival rate (190) 190
tumors (189) 189
induction chemotherapy (187) 187
therapy (187) 187
cisplatin (186) 186
expression (184) 184
time factors (184) 184
medicine, research & experimental (181) 181
organ preservation (180) 180
health aspects (176) 176
advanced laryngeal-cancer (175) 175
papilloma - drug therapy (175) 175
disease-free survival (174) 174
radiation therapy (172) 172
child, preschool (171) 171
fluorouracil - administration & dosage (167) 167
medicine & public health (166) 166
radiotherapy dosage (166) 166
drug therapy (165) 165
laryngeal neoplasms - genetics (160) 160
survival (160) 160
prospective studies (158) 158
radiation (158) 158
radiology, nuclear medicine & medical imaging (156) 156
chemoradiotherapy (155) 155
pharyngeal neoplasms - drug therapy (155) 155
infant (152) 152
immunohistochemistry (151) 151
mice (145) 145
risk factors (145) 145
carcinoma, squamous cell - metabolism (144) 144
laryngoscopy (143) 143
laryngeal neoplasms (142) 142
oncology, experimental (142) 142
laryngeal carcinoma (140) 140
survival analysis (139) 139
antineoplastic agents - administration & dosage (135) 135
metastasis (134) 134
cancer therapies (132) 132
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (35) 35
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (2) 2
Providence Healthcare - Reference (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Circulation Desk (1) 1
Scarborough Hospital - General (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2844) 2844
Russian (116) 116
French (108) 108
German (105) 105
Japanese (61) 61
Chinese (58) 58
Spanish (41) 41
Polish (33) 33
Italian (23) 23
Romanian (6) 6
Dutch (5) 5
Czech (4) 4
Portuguese (4) 4
Danish (3) 3
Hebrew (3) 3
Hungarian (3) 3
Serbian (3) 3
Slovak (2) 2
Turkish (2) 2
Croatian (1) 1
Finnish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 96, Issue 5, pp. 967 - 975
Purpose To assess the impact of radiation treatment time (RTT) in head and neck cancers on overall survival (OS) in the era of chemoradiation. Methods and... 
Radiology | Hematology, Oncology and Palliative Medicine | ONCOLOGY | CONCURRENT CHEMOTHERAPY | LARYNGEAL-CANCER | THERAPY ONCOLOGY GROUP | SQUAMOUS-CELL CARCINOMA | RANDOMIZED-TRIAL | STANDARD FRACTIONATION | LOCALLY ADVANCED HEAD | 1ST REPORT | PROLONGATION | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Radiotherapy - mortality | Humans | Oropharyngeal Neoplasms - mortality | Chemoradiotherapy - mortality | Hypopharyngeal Neoplasms - mortality | Tongue Neoplasms - drug therapy | Time Factors | Laryngeal Neoplasms - drug therapy | Tongue Neoplasms - radiotherapy | Tongue Neoplasms - mortality | Chemoradiotherapy - methods | Oropharyngeal Neoplasms - drug therapy | Head and Neck Neoplasms - drug therapy | Kaplan-Meier Estimate | Oropharyngeal Neoplasms - radiotherapy | Chi-Square Distribution | Tonsillar Neoplasms - mortality | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Analysis of Variance | Laryngeal Neoplasms - mortality | Tonsillar Neoplasms - radiotherapy | Survival Analysis | Tonsillar Neoplasms - drug therapy | Head and Neck Neoplasms - mortality | Hypopharyngeal Neoplasms - drug therapy | Care and treatment | Cancer patients | Radiotherapy | Patient outcomes | Radiation | Cancer | Index Medicus | HEAD | PATIENTS | SURVIVAL TIME | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LYMPHATIC SYSTEM | CHEMOTHERAPY | Head and Neck Cancer | Treatment time | National Cancer Database | Squamous Cell
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 5, pp. 1360 - 1368
Purpose The aim of this study was to investigate prospectively the weekly volume changes in the target volumes and organs at risk and the resulting dosimetric... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Volume changes | Chemo-IMRT | Dosimetric changes | SYSTEM | DELINEATION | IMRT | ONCOLOGY | GUIDELINES | RADIOTHERAPY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Prospective Studies | Humans | Oropharyngeal Neoplasms - diagnostic imaging | Spinal Cord - radiation effects | Laryngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - pathology | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - pathology | Nasopharyngeal Neoplasms - radiotherapy | Fluorouracil - administration & dosage | Time Factors | Laryngeal Neoplasms - drug therapy | Nasopharyngeal Neoplasms - drug therapy | Brain Stem - radiation effects | Radiotherapy Dosage | Nasopharyngeal Neoplasms - diagnostic imaging | Oropharyngeal Neoplasms - drug therapy | Parotid Gland - diagnostic imaging | Head and Neck Neoplasms - diagnostic imaging | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Head and Neck Neoplasms - pathology | Radiography | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Parotid Gland - radiation effects | Hypopharyngeal Neoplasms - pathology | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Hypopharyngeal Neoplasms - diagnostic imaging | Care and treatment | Chemotherapy | Oncology, Experimental | Radiation | Research | Radiotherapy | Cancer | Index Medicus | TOMOGRAPHY | HEAD | DIAGNOSTIC TECHNIQUES | NEOPLASMS | RADIATION DOSES | MEDICINE | COMPUTERIZED TOMOGRAPHY | CHEMOTHERAPY | NUCLEAR MEDICINE | CAT SCANNING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY | RADIOLOGY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2013, Volume 87, Issue 5, pp. 1078 - 1085
Purpose To compare the temporal lymph node (LN) regression and regional control (RC) after primary chemoradiation therapy/radiation therapy in human... 
Radiology | Hematology, Oncology and Palliative Medicine | METASTASIS | ONCOLOGY | DISSECTION | OROPHARYNGEAL CANCER | LYMPH-NODES | SQUAMOUS-CELL CARCINOMA | CHEMORADIATION | CHEMORADIOTHERAPY | HUMAN-PAPILLOMAVIRUS | RADIOTHERAPY | ONCOLOGY GROUP | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Multivariate Analysis | Head and Neck Neoplasms - virology | Lymph Nodes - pathology | Hypopharyngeal Neoplasms - virology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Laryngeal Neoplasms - pathology | Lymph Nodes - radiation effects | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Papillomavirus Infections - virology | Remission Induction - methods | Oropharyngeal Neoplasms - drug therapy | Laryngeal Neoplasms - surgery | Head and Neck Neoplasms - drug therapy | Organ Size | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Lymph Nodes - virology | Oropharyngeal Neoplasms - virology | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Oropharyngeal Neoplasms - surgery | Hypopharyngeal Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Head and Neck Neoplasms - surgery | Cohort Studies | Laryngeal Neoplasms - virology | Neck Dissection | Sects | Care and treatment | Radiotherapy | Nuclear radiation | Papillomavirus infections | Cancer | Index Medicus | HEAD | MULTIVARIATE ANALYSIS | NEOPLASMS | LYMPH NODES | POSITRON COMPUTED TOMOGRAPHY | CHARGES | RADIOLOGY AND NUCLEAR MEDICINE | NECK | LARYNX | HAZARDS
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 1, pp. 126 - 134
Purpose To perform a comprehensive cognitive function (CF) assessment in patients who were relapse free after curative intent radiotherapy (RT) or... 
Radiology | Hematology, Oncology and Palliative Medicine | Squamous cell carcinoma of the head and neck | Chemotherapy | Neuropsychological testing | Radiotherapy | Cognitive dysfunction | PROPHYLACTIC CRANIAL IRRADIATION | ADJUVANT CHEMOTHERAPY | DRIVING PERFORMANCE | FOLLOW-UP | CELL LUNG-CANCER | BREAST-CANCER | NASOPHARYNGEAL CARCINOMA | ONCOLOGY | NEUROCOGNITIVE FUNCTION | LOW-GRADE GLIOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Pharyngeal Neoplasms - radiotherapy | Cerebellum - radiation effects | Prospective Studies | Humans | Middle Aged | Male | Pharyngeal Neoplasms - drug therapy | Antineoplastic Agents - administration & dosage | Cognition - physiology | Laryngeal Neoplasms - drug therapy | Neoplasms, Squamous Cell - pathology | Carcinoma - drug therapy | Carcinoma - blood | Affect - physiology | Head and Neck Neoplasms - drug therapy | Cognition - drug effects | Neoplasms, Squamous Cell - blood | Head and Neck Neoplasms - pathology | Carcinoma, Squamous Cell | Neuropsychological Tests | Cognition Disorders - diagnosis | Memory Disorders - etiology | Hypopharyngeal Neoplasms - pathology | Quality of Life | Pharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - drug therapy | Temporal Lobe - drug effects | Laryngeal Neoplasms - blood | Cerebellum - drug effects | Hypopharyngeal Neoplasms - blood | Cisplatin - administration & dosage | Feasibility Studies | Laryngeal Neoplasms - pathology | Squamous Cell Carcinoma of Head and Neck | Head and Neck Neoplasms - blood | Antineoplastic Agents - adverse effects | Cognition Disorders - etiology | Neoplasms, Squamous Cell - drug therapy | Neoplasms, Squamous Cell - radiotherapy | Female | Carcinoma - pathology | Cognition - radiation effects | Affect - drug effects | Pharyngeal Neoplasms - blood | Affect - radiation effects | Carcinoma - radiotherapy | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Temporal Lobe - radiation effects | Care and treatment | Squamous cell carcinoma | Cancer | Index Medicus | BODY FLUIDS | HEAD | NERVOUS SYSTEM | RADIATION DOSES | MEDICINE | THERAPY | CEREBELLUM | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | COMBINED THERAPY | BRAIN | RADIOLOGY | BLOOD | NEOPLASMS | BIOLOGICAL MATERIALS | CENTRAL NERVOUS SYSTEM | STANDARD OF LIVING | CHEMOTHERAPY | NUCLEAR MEDICINE | ORGANS | DISEASES | DOSES | CARCINOMAS | NECK | DOSIMETRY | BODY | MATERIALS
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 853 - 859
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 79, Issue 2, pp. 429 - 435
Purpose Volumetric modulated arc therapy (RapidArc, Varian Medical Systems) permits the delivery of highly conformal dose distributions. We studied planning... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Locally advanced disease | Volumetric modulated arc therapy | RapidArc | Dose distribution | DYSPHAGIA | CONVENTIONAL RADIOTHERAPY | SINGLE-ARC IMRT | OROPHARYNGEAL CARCINOMA | VOLUME RESPONSE ANALYSIS | 2ND CANCERS | PAROTID-GLAND FUNCTION | MODULATED RADIATION-THERAPY | DELINEATION | IMPACT | ONCOLOGY | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Radiotherapy Dosage | Organs at Risk - radiation effects | Oropharyngeal Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted - methods | Humans | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Tumor Burden | Head and Neck Neoplasms - pathology | Laryngeal Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - pathology | Laryngeal Neoplasms - drug therapy | Combined Modality Therapy - methods | Hypopharyngeal Neoplasms - drug therapy | Phantoms, Imaging | Film Dosimetry | Care and treatment | Cancer patients | Cancer | Index Medicus | HEAD | RADIATION DOSE DISTRIBUTIONS | DISEASES | THERAPY | NEOPLASMS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | MEDICINE | BODY | COMBINED THERAPY | DELIVERY | PLANNING
Journal Article
Laryngoscope, ISSN 0023-852X, 09/2009, Volume 119, Issue 9, pp. 1709 - 1719
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1356 - 1365
Purpose To investigate long-term swallowing function in oropharyngeal cancer patients treated with intensity-modulated radiotherapy (IMRT), and to identify... 
Radiology | Hematology, Oncology and Palliative Medicine | IMRT | Toxicity | Radiation | Head and neck cancer | Dysphagia | Dose–volume constraints | Swallowing | Dose-volume constraints | NECK-CANCER PATIENTS | HEAD | ASPIRATION | CHEMOTHERAPY | DOSE-VOLUME HISTOGRAMS | ONCOLOGY | PROSTATE-CANCER | SQUAMOUS-CELL CARCINOMA | QUALITY-OF-LIFE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Organs at Risk - radiation effects | Oropharynx - diagnostic imaging | Prospective Studies | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Oropharyngeal Neoplasms - pathology | Carcinoma, Squamous Cell - radiotherapy | Oropharynx - physiopathology | Radiotherapy, Intensity-Modulated - adverse effects | Tongue Neoplasms - drug therapy | Radiation Protection | Adult | Deglutition Disorders - etiology | Female | Oropharynx - radiation effects | Tongue Neoplasms - radiotherapy | Radiotherapy Dosage | Deglutition - radiation effects | Tonsillar Neoplasms - pathology | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Laryngeal Muscles - diagnostic imaging | Oropharyngeal Neoplasms - radiotherapy | Tumor Burden | Deglutition - physiology | Tongue Neoplasms - pathology | Radiography | Carcinoma, Squamous Cell - drug therapy | Analysis of Variance | Radiation Injuries - prevention & control | Tonsillar Neoplasms - radiotherapy | Organs at Risk - diagnostic imaging | Tonsillar Neoplasms - drug therapy | Aged | Combined Modality Therapy - methods | Laryngeal Muscles - radiation effects | Neoplasm Staging | Index Medicus | ORAL CAVITY | NEOPLASMS | STATISTICS | DIGESTIVE SYSTEM | RADIATION DOSES | LARYNX | MEDICINE | NUCLEAR MEDICINE | PHARYNX | TONGUE | MATHEMATICS | MULTIVARIATE ANALYSIS | ORGANS | DISEASES | THERAPY | DOSES | RESPIRATORY SYSTEM | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | RADIOLOGY
Journal Article
Annals of Oncology, ISSN 0923-7534, 5/2009, Volume 20, Issue 5, pp. 921 - 927
Background: Locally advanced laryngeal and hypopharyngeal cancers (LHC) represent a group of cancers for which surgery, laryngectomy-free survival (LFS),... 
Head and neck cancer | Chemotherapy | Hypopharynx cancer | Larynx cancer | Organ preservation | Chemoradiotherapy | larynx cancer | head and neck cancer | chemoradiotherapy | FLUOROURACIL | chemotherapy | ADVANCED HEAD | RADIATION | DOCETAXEL | hypopharynx cancer | NECK-CANCER | PHASE-III TRIAL | NEOADJUVANT CHEMOTHERAPY | CISPLATIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | CARCINOMA | organ preservation | Laryngeal Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - surgery | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Male | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Laryngectomy | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Laryngeal Neoplasms - therapy | Carcinoma, Squamous Cell - mortality | Fluorouracil - administration & dosage | Time Factors | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Adult | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Laryngeal Neoplasms - surgery | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Carcinoma, Squamous Cell - therapy | Treatment Outcome | Hypopharyngeal Neoplasms - therapy | Disease-Free Survival | Hypopharyngeal Neoplasms - radiotherapy | Taxoids - administration & dosage | Carcinoma, Squamous Cell - drug therapy | Laryngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Hypopharyngeal Neoplasms - pathology | Aged | Hypopharyngeal Neoplasms - drug therapy | Index Medicus
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2009, Volume 74, Issue 2, pp. 477 - 481
Purpose To describe the University of Miami experience in the treatment of small cell carcinoma of the head and neck. Methods and Materials A total of 12... 
Radiology | Hematology, Oncology and Palliative Medicine | Head and neck cancer | Small cell | Chemotherapy | Radiotherapy | ONCOLOGY | LARYNX | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Nasopharyngeal Neoplasms - mortality | Humans | Middle Aged | Male | Carcinoma, Small Cell - mortality | Universities | Nasopharyngeal Neoplasms - radiotherapy | Nose Neoplasms - radiotherapy | Parotid Neoplasms - radiotherapy | Aged, 80 and over | Laryngeal Neoplasms - drug therapy | Female | Retrospective Studies | Nasopharyngeal Neoplasms - drug therapy | Carcinoma, Small Cell - drug therapy | Carcinoma, Small Cell - radiotherapy | Head and Neck Neoplasms - drug therapy | Florida | Tonsillar Neoplasms - mortality | Disease-Free Survival | Head and Neck Neoplasms - radiotherapy | Laryngeal Neoplasms - mortality | Parotid Neoplasms - mortality | Tonsillar Neoplasms - radiotherapy | Nose Neoplasms - drug therapy | Tonsillar Neoplasms - drug therapy | Aged | Combined Modality Therapy - methods | Parotid Neoplasms - drug therapy | Head and Neck Neoplasms - mortality | Nose Neoplasms - mortality | Carcinoma | Universities and colleges | Cancer | Index Medicus | SURGERY | HEAD | PATIENTS | CAVITIES | FAILURES | LYMPHATIC SYSTEM | CHEMOTHERAPY | PHARYNX | SURVIVAL TIME | GLANDS | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | RADIOTHERAPY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 3, pp. 696 - 702
Purpose Erlotinib, an oral tyrosine kinase inhibitor, is active against head-and-neck squamous cell carcinoma (HNSCC) and possibly has a synergistic... 
Radiology | Hematology, Oncology and Palliative Medicine | Chemotherapy | Squamous cell carcinoma | Erlotinib | Radiotherapy | Epidermal growth factor receptor | PROSPECTIVE RANDOMIZED-TRIAL | PRIMARY LARYNGEAL-CANCER | CHEMORADIOTHERAPY | STAGE-III | RADIATION-THERAPY | GROWTH-FACTOR RECEPTOR | ONCOLOGY | CONCURRENT CHEMOTHERAPY | TGF-ALPHA | AERODIGESTIVE TRACT CANCER | EXPRESSION | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Erlotinib Hydrochloride | Laryngeal Neoplasms - radiotherapy | Confidence Intervals | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carcinoma, Squamous Cell - surgery | Male | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Cisplatin - administration & dosage | Laryngeal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Brazil | Laryngeal Neoplasms - drug therapy | Adult | Female | Quinazolines - administration & dosage | Radiotherapy Dosage | Drug Eruptions - etiology | Oropharyngeal Neoplasms - drug therapy | Drug Administration Schedule | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Survival Rate | Combined Modality Therapy - adverse effects | Head and Neck Neoplasms - pathology | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Quinazolines - adverse effects | Cisplatin - adverse effects | Aged | Combined Modality Therapy - methods | Head and Neck Neoplasms - mortality | Hypopharyngeal Neoplasms - drug therapy | Head and Neck Neoplasms - surgery | Salvage Therapy - methods | Tyrosine | Medical research | Care and treatment | Medicine, Experimental | Clinical trials | Cisplatin | Cancer | Index Medicus | HEAD | MITOGENS | RADIATION DOSES | MEDICINE | THERAPY | TYROSINE | AMINO ACIDS | DRUGS | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | MEMBRANE PROTEINS | NEOPLASMS | ORGANIC COMPOUNDS | HYDROXY ACIDS | ORGANIC ACIDS | TOXICITY | ANTINEOPLASTIC DRUGS | CHEMOTHERAPY | NUCLEAR MEDICINE | GROWTH FACTORS | DISEASES | DOSES | CARCINOMAS | CARBOXYLIC ACIDS | NECK | RECEPTORS | PROTEINS | BODY
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 78, Issue 5, pp. 1373 - 1380
Purpose To review outcome and toxicity of Stage IVa and IVb head-and-neck squamous cell carcinoma patients treated with concomitant chemotherapy and... 
Radiology | Hematology, Oncology and Palliative Medicine | Head-and-neck cancer | Altered fractionation | Chemotherapy | IMRT | Head-and neck cancer | ACCELERATED RADIOTHERAPY | TOXICITY | OROPHARYNGEAL CARCINOMA | CANCER | RADIATION-THERAPY | DELINEATION | ONCOLOGY | CONCURRENT CHEMOTHERAPY | CONFORMAL RADIOTHERAPY | LOCALLY ADVANCED HEAD | EXPERIENCE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Laryngeal Neoplasms - radiotherapy | Mouth Neoplasms - drug therapy | Radiotherapy Planning, Computer-Assisted - methods | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Oropharyngeal Neoplasms - mortality | Male | Antineoplastic Agents - therapeutic use | Oropharyngeal Neoplasms - pathology | Hypopharyngeal Neoplasms - mortality | Carcinoma, Squamous Cell - radiotherapy | Radiotherapy, Intensity-Modulated - adverse effects | Laryngeal Neoplasms - pathology | Carcinoma, Squamous Cell - mortality | Laryngeal Neoplasms - drug therapy | Adult | Dose Fractionation | Female | Mouth Neoplasms - radiotherapy | Retrospective Studies | Oropharyngeal Neoplasms - drug therapy | Radiotherapy, Intensity-Modulated - methods | Head and Neck Neoplasms - drug therapy | Oropharyngeal Neoplasms - radiotherapy | Treatment Outcome | Combined Modality Therapy - adverse effects | Mouth Neoplasms - mortality | Head and Neck Neoplasms - pathology | Radiography | Xerostomia - prevention & control | Head and Neck Neoplasms - radiotherapy | Hypopharyngeal Neoplasms - radiotherapy | Carcinoma, Squamous Cell - drug therapy | Cisplatin - therapeutic use | Laryngeal Neoplasms - mortality | Hypopharyngeal Neoplasms - pathology | Organs at Risk - diagnostic imaging | Survival Analysis | Mouth Neoplasms - pathology | Aged | Combined Modality Therapy - methods | Head and Neck Neoplasms - mortality | Hypopharyngeal Neoplasms - drug therapy | Neoplasm Staging | Index Medicus | HEAD | NEOPLASMS | MEDICINE | IRRADIATION | FRACTIONATED IRRADIATION | DISEASES | THERAPY | CARCINOMAS | RADIOLOGY AND NUCLEAR MEDICINE | NECK | BODY | COMBINED THERAPY
Journal Article